| ACTIVE PHARMACEUTICAL
INGREDIENTS current production |
| PRODUCT |
CAS |
 |
| amisulpride
|
71675-85-9 |
| bisbuthylcarboethylene |
105-76-0 |
| bromopride |
4093-35-0 |
| calcium dobesilate |
20123-80-2 |
| dibromotyrosine |
300-38-9 |
| epinastine HCl |
80012-44-8 |
| ethamsylate |
2624-44-4 |
| glibenclamide (glyburide) |
10238-21-8 |
glipizide
|
29094-61-9 |
gliquidone
|
33342-05-1 |
levosulpiride
|
23672-07-3 |
| metoclopramide |
364-62-5 |
| metoclopramide HCl |
54143-57-6 |
| minoxidil |
38304-91-5 |
| minoxidil sulphate |
83701-22-8 |
pentetrazole
|
54-95-5 |
| sulpiride |
15676-16-1 |
sultopride HCl
|
23694-17-9 |
tiapride HCl
|
51012-33-0 |
| veralipride |
66644-81-3 |
| |
|
| ACTIVE PHARMACEUTICAL INGREDIENTS under development |
amorolfine
|
78613-35-1 |
| citalopram HBr |
59729-32-7 |
| diacerein |
13739-02-1 |
| glimepiride |
93479-97-1 |
| itopride HCl |
122892-31-3 |
mirtazapine
|
61337-67-5 |
| pinaverium bromide |
35251-94-8 |
| |
|
| Sales of products are limited to those allowed by Section 35 USC 271(e)(1) |
